Author

Joseph Scaduto

Institution: Traverse Biosciences (United States)

Observed institution: Traverse Biosciences (United States)

ORCID: 0000-0003-2295-9047

Observed ORCID: 0000-0003-2295-9047

OpenAlex ID: A5083459033

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

2020 · Jie Deng, Lorne M Golub, et al. · Journal of Experimental Pharmacology · 38

Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications

2019 · Howard Wang, Hsi-Ming Lee, et al. · Journal of Experimental Pharmacology · 25

A Novel Chemically-Modified Curcumin 2.24: Short-Term Systemic Therapy for Natural Periodontitis in Dogs

2021 · Jie Deng, Lorne M. Golub, et al. · Frontiers in Dental Medicine · 7

Medu-36. Meriva® and a Novel Chemically-modified Curcumin for the Treatment of Medulloblastoma

2017 · Avery Wright, Benjamin Stuart, et al. · Neuro-Oncology · 3

A curcumin derivative metalloprotease inhibitor (CMC2.24) mitigates Brachyspira spp.-induced swine dysentery

2025 · Rodrigo Puentes, Niloofar Mirzadzare, et al. · International Immunopharmacology · 2

A Novel Chemically-Modified Curcumin 2.24: Short-term Systemic Treatment for Natural Periodontitis in Dogs

2020 · JIE DENG, Lorne M Golub, et al. · Research Square · 2

Proteolytic dysfunction in bovine digital dermatitis caused by Treponema spp. and the therapeutic use of non-antimicrobial matrix metalloproteinase inhibitors

2025 · Priyoshi Lahiri, Daniel Young, et al. · Communications Biology · 1

Abstract 2481A: A novel chemically-modified curcumin (CMC 2.24) promotes chemosensitivity in neuroblastoma

2016 · David Tauber, Basia Galinski, et al. · Cancer Research · 1

Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]

2020 · Howard Wang, Hsi-Ming Lee, et al. · Journal of Experimental Pharmacology

Works count: 9

Citation count: 79

H-index: 3

I10-index: 2